AC Immune SA (ACIU) Stock: Buy, Sell, or Hold?
ACIU - AC Immune SA
$2.76
0.07 (2.60%)
â˛
5d:
-5.8%
30d:
+5.34%
90d:
+22.12%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ACIU is fairly priced but lacks strong directional signals. At -24.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ACIU is fairly priced but lacks strong directional signals. At -24.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.82
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.48
49.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.76, which is considered slightly high relative to its 30-day fair value range of $2.46 to $2.84. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.6) compared to its historical average (12.7). Remarkably, the market is currently pricing in an annual earnings decline of 24.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is in a downtrend. Immediate support is located at $2.58, while resistance sits at $3.00.
Market Sentiment: ACIU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.46 (+206.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACIU is in a downtrend. Immediate support is located at $2.58, while resistance sits at $3.00.
Market Sentiment: ACIU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.46 (+206.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.46 -
$2.84
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.9%
All Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 206.3% below Wall St target ($8.46)
- WARNING: Composite score 35/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.46 -
$2.84
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.58
Resistance Level
$3.00
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.57
Wall Street Target
$8.46
(+206.3%)
Revenue Growth (YoY)
1057.2%
Profit Margin
-246.5%
Valuation Discount vs History
-24.1% cheaper
PE vs Historical
5.6 vs 12.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.1%
(market-implied from PE analysis)
1-Year Target
$2.48
(-10%)
2-Year Target
$2.24
(-19%)
3-Year Target
$2.01
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6â13)
$4.59
(+66%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.6 to 12.7
Stabilization Target:
$6.30
(+128.1%)
PE Expansion Potential:
+128.1%
Share & Embed Analysis
Last updated: September 13, 2026 8:37 AM ET
Data refreshes hourly during market hours. Next update: 9:37 AM
Data refreshes hourly during market hours. Next update: 9:37 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 41 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
BUY
20 analysts |
$34 | 52 HOLD |
